COMMUNIQUÉS West-GlobeNewswire
-
Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update
13/11/2025 -
La MHRA approuve la demande d’essai clinique de BetaGlue Therapeutics pour YntraDose™ dans le traitement du cancer du pancréas localement avancé non résécable (uLA-PDAC)
13/11/2025 -
SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update
13/11/2025 -
Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers
13/11/2025 -
GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector
13/11/2025 -
GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes
13/11/2025 -
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
13/11/2025 -
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
13/11/2025 -
MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial
13/11/2025 -
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
13/11/2025 -
Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium)
13/11/2025 -
Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
13/11/2025 -
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
13/11/2025 -
Kura Oncology and Kyowa Kirin Announce FDA Approval of KOMZIFTI™ (ziftomenib), the First and Only Once-Daily Targeted Therapy for Adults with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia
13/11/2025 -
Legend Senior Living® Expands Presence to New Jersey, Welcoming Azalea of Cinnaminson
13/11/2025 -
Inventiva announces trading resumption of its ordinary shares on Euronext Paris
13/11/2025 -
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
13/11/2025 -
Zone School of Healing Celebrates Eight-Year Milestone as One of the Fastest-Growing Chiropractic & Healing Schools Worldwide
13/11/2025 -
U.S. Oral Surgery Management Secures New Partner Practices in Three States
13/11/2025
Pages